# L_2006275EN.01005101.xml

| 6.10.2006 | EN | Official Journal of the European Union | L 275/51 |
| --- | --- | --- | --- |

6.10.2006

EN

Official Journal of the European Union

L 275/51

---

COMMISSION DECISION

of 29 September 2006

concerning a financial contribution from the Community towards a baseline survey on the prevalence of Salmonella in slaughter pigs to be carried out in the Member States

(notified under document number C(2006) 4306)

(2006/668/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (1), and in particular Article 20 thereof,

Whereas:

| (1) | Pursuant to Decision 90/424/EEC the Community is to undertake or assist the Member States in undertaking the technical and scientific measures necessary for the development of veterinary legislation and for the development of veterinary education or training. |
| --- | --- |

(1)

Pursuant to Decision 90/424/EEC the Community is to undertake or assist the Member States in undertaking the technical and scientific measures necessary for the development of veterinary legislation and for the development of veterinary education or training.

| (2) | Under Article 4 of Regulation (EC) No 2160/2003 of the European Parliament and of the Council of 17 November 2003 on the control of Salmonella and other specified food-borne zoonotic agents (2), a Community target is to be established for reducing the prevalence of Salmonella in populations of herds of slaughter pigs by the end of 2007. |
| --- | --- |

(2)

Under Article 4 of Regulation (EC) No 2160/2003 of the European Parliament and of the Council of 17 November 2003 on the control of Salmonella and other specified food-borne zoonotic agents (2), a Community target is to be established for reducing the prevalence of Salmonella in populations of herds of slaughter pigs by the end of 2007.

| (3) | The Scientific Panel on Biological Hazards of the European Food Safety Authority (EFSA) adopted an opinion on the request from the Commission related to ‘Risk assessment and mitigation options of Salmonella in pig production’, during its meeting of 16 March 2006. The opinion proposes technical specifications for a baseline study on the prevalence of Salmonella in fattening pigs in the EU. |
| --- | --- |

(3)

The Scientific Panel on Biological Hazards of the European Food Safety Authority (EFSA) adopted an opinion on the request from the Commission related to ‘Risk assessment and mitigation options of Salmonella in pig production’, during its meeting of 16 March 2006. The opinion proposes technical specifications for a baseline study on the prevalence of Salmonella in fattening pigs in the EU.

| (4) | In order to set the Community target, comparable data on the prevalence of Salmonella in populations of slaughter pigs in the Member States needs to be available. Such information is not at hand and a special survey should therefore be carried out to monitor the prevalence of Salmonella in slaughter pigs over a suitable period in order to take account of possible seasonal variations. |
| --- | --- |

(4)

In order to set the Community target, comparable data on the prevalence of Salmonella in populations of slaughter pigs in the Member States needs to be available. Such information is not at hand and a special survey should therefore be carried out to monitor the prevalence of Salmonella in slaughter pigs over a suitable period in order to take account of possible seasonal variations.

| (5) | The EFSA opinion recommends slaughterhouse sampling by taking ileocaecal lymph nodes to reflect the Salmonella status of the pig sent to slaughter. Such sampling should therefore be used as a tool to monitor the prevalence of Salmonella in slaughter pigs. It is opportune to use this baseline survey also to evaluate the effect of contamination of the pigs during transport and lairage, and contamination of the carcase during the slaughter process by taking carcase swabs. In addition, serological methods have been developed to assess the Salmonella status of a pig and may be used for monitoring Salmonella in pigs within the frame of national control programmes to be implemented in accordance with Article 5 of Regulation (EC) No 2160/2003. |
| --- | --- |

(5)

The EFSA opinion recommends slaughterhouse sampling by taking ileocaecal lymph nodes to reflect the Salmonella status of the pig sent to slaughter. Such sampling should therefore be used as a tool to monitor the prevalence of Salmonella in slaughter pigs. It is opportune to use this baseline survey also to evaluate the effect of contamination of the pigs during transport and lairage, and contamination of the carcase during the slaughter process by taking carcase swabs. In addition, serological methods have been developed to assess the Salmonella status of a pig and may be used for monitoring Salmonella in pigs within the frame of national control programmes to be implemented in accordance with Article 5 of Regulation (EC) No 2160/2003.

| (6) | A number of Member States volunteered to carry out the additional analyses by taking carcase swabs or carrying out serology on meat juice. |
| --- | --- |

(6)

A number of Member States volunteered to carry out the additional analyses by taking carcase swabs or carrying out serology on meat juice.

| (7) | The survey is to provide technical information necessary for the development of Community veterinary legislation. Given the importance of collecting comparable data on the prevalence of Salmonella in slaughter pigs in the Member States, they should be granted a Community financial contribution for implementing the specific requirements of the survey. It is appropriate to reimburse 100 % of the costs incurred on the laboratory testing, subject to a ceiling. All other costs such as sampling, travel, administration, etc should not be eligible for any Community financial contribution. |
| --- | --- |

(7)

The survey is to provide technical information necessary for the development of Community veterinary legislation. Given the importance of collecting comparable data on the prevalence of Salmonella in slaughter pigs in the Member States, they should be granted a Community financial contribution for implementing the specific requirements of the survey. It is appropriate to reimburse 100 % of the costs incurred on the laboratory testing, subject to a ceiling. All other costs such as sampling, travel, administration, etc should not be eligible for any Community financial contribution.

| (8) | A financial contribution from the Community should be granted provided that the survey is carried out in accordance with the relevant provisions of Community law and subject to compliance with certain other conditions. |
| --- | --- |

(8)

A financial contribution from the Community should be granted provided that the survey is carried out in accordance with the relevant provisions of Community law and subject to compliance with certain other conditions.

| (9) | A financial contribution from the Community should be granted in so far as the actions provided for are effectively carried out and provided that the authorities furnish all the necessary information within the time limits provided for. |
| --- | --- |

(9)

A financial contribution from the Community should be granted in so far as the actions provided for are effectively carried out and provided that the authorities furnish all the necessary information within the time limits provided for.

| (10) | There is a need to clarify the rate to be used for the conversion of payment applications submitted in national currencies as defined in Article 1(d) of Council Regulation (EC) No 2799/98 of 15 December 1998 establishing agrimonetary arrangements for the euro (3). |
| --- | --- |

(10)

There is a need to clarify the rate to be used for the conversion of payment applications submitted in national currencies as defined in Article 1(d) of Council Regulation (EC) No 2799/98 of 15 December 1998 establishing agrimonetary arrangements for the euro (3).

| (11) | The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health, |
| --- | --- |

(11)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1

Objective of the survey and general provisions

1.   A survey shall be carried out to assess the prevalence of Salmonella spp. across the Community in slaughter pigs sampled in the slaughter house. The survey shall also be used to collect at the same time information on contamination of carcases in slaughterhouses and on the relation between bacteriological and serological tests.

2.   The results of the survey shall be used to set Community targets as provided for in Article 4 of Regulation (EC) No 2160/2003 and to consider the best approach to evaluate in the future the achievement of the target.

3.   The survey shall cover a one-year period commencing on 1 October 2006.

4.   For the purposes of this Decision, ‘competent authority’ shall be the authority or authorities of a Member State as designated under Article 3 of Regulation (EC) No 2160/2003.

Article 2

Technical specifications

The survey in slaughter pigs shall be organised by the Member States and shall be performed from 1 October 2006 in slaughterhouses. Sampling and analysis shall be performed by the competent authority or under its supervision.

Sampling and analysis shall be performed in accordance with the provisions in Annex I.

Article 3

Collection of data, assessment and reporting

1.   The competent authority responsible for preparing the yearly national report pursuant to Article 9(1) of Directive 2003/99/EC of the European Parliament and of the Council (4) shall collect and assess the results achieved pursuant to Article 2 of this Decision and shall report all necessary data and its assessment to the Commission.

2.   The Commission shall forward the results to the European Food Safety authority, which shall examine them.

3.   National aggregated data and results shall be made available publicly in a form that ensures confidentiality.

Article 4

Scope of the Community financial contribution

1.   The Community shall provide financial contribution for the costs incurred by the Member States on laboratory testing, i.e. bacteriological detection of Salmonella spp., serotyping of the relevant isolates and serology.

2.   The maximum financial contribution from the Community shall be EUR 20 per test for bacteriological detection of Salmonella spp., EUR 30 for serotyping of the relevant isolates and EUR 10 for serology on meat juice.

3.   The financial contribution from the Community shall not exceed the amounts set out in Annex II for the duration of the survey.

Article 5

Conditions for granting a Community financial contribution

1.   The financial contribution provided for in Article 4 shall be granted to the Member States provided that the survey is implemented in accordance with the relevant provisions of Community law, including the rules on competition and on the award of public contracts, and subject to compliance with the following conditions:

| (a) | by 1 October 2006, the laws, regulations and administrative provisions required to implement the survey shall come into force; |
| --- | --- |

(a)

by 1 October 2006, the laws, regulations and administrative provisions required to implement the survey shall come into force;

| (b) | a progress report covering the first three months of the survey shall be forwarded by 28 February 2007. The progress report should contain all information requested in Annex III of the Opinion of the Scientific Panel on Biological Hazards on the request from the Commission related to ‘Risk assessment and mitigation options of Salmonella in pig production’. |
| --- | --- |

(b)

a progress report covering the first three months of the survey shall be forwarded by 28 February 2007. The progress report should contain all information requested in Annex III of the Opinion of the Scientific Panel on Biological Hazards on the request from the Commission related to ‘Risk assessment and mitigation options of Salmonella in pig production’.

| (c) | a final report shall be forwarded by 31 October 2007 at the latest on the technical execution of the survey, together with supporting evidence for the costs incurred and the results attained during the period 1 October 2006 to 30 September 2007; the evidence as to costs incurred shall comprise at least the information set out in Annex III; |
| --- | --- |

(c)

a final report shall be forwarded by 31 October 2007 at the latest on the technical execution of the survey, together with supporting evidence for the costs incurred and the results attained during the period 1 October 2006 to 30 September 2007; the evidence as to costs incurred shall comprise at least the information set out in Annex III;

| (d) | the survey shall be implemented effectively. |
| --- | --- |

(d)

the survey shall be implemented effectively.

2.   An advance of 50 % of the total amount referred to in Annex II may be paid at the request of the Member State concerned.

3.   Failure to comply with the time limit in paragraph 1(c) shall entail a progressive reduction of the financial contribution to be paid, amounting to 25 % of the total amount by 15 November 2007, 50 % by 1 December 2007 and 100 % by 15 December 2007.

Article 6

Conversion rate for applications in national currencies

The conversion rate for applications submitted in national currencies in month ‘n’ shall be that for the 10th day of month ‘n+1’ or the first day before that day for which a rate is quoted.

Article 7

Application

This Decision shall apply from 1 October 2006.

Article 8

Addressees

This Decision is addressed to the Member States.

Done at Brussels, 29 September 2006.

For the Commission

Markos KYPRIANOU

Member of the Commission

---

(1)  
  OJ L 224, 18.8.1990, p. 19. Decision as last amended by Decision 2006/53/EC (OJ L 29, 2.2.2006, p. 37).

1

(2)  
  OJ L 325, 12.12.2003, p. 1. Regulation as amended by Commission Regulation (EC) No 1003/2005 (OJ L 170, 1.7.2005, p. 12).

2

(3)  
  OJ L 349, 24.12.1998, p. 1.

3

(4)  
  OJ L 325, 12.12.2003, p. 31.

4

---

ANNEX I

Technical specifications in accordance with Article 2

1.   Sampling frame

A minimum number of pigs, kept during at least the preceding three months in the Member State, shall be ad random sampled in accordance with Table 1.

Table 1

Minimum sample size

| Number of pigs present in the population | Minimum sample size (1) |
| --- | --- |
| > 20 000 000 | 2 400 |
| 10 to 20 000 000 | 1 067 |
| 2 to 10 000 000 | 600 |
| < 2 000 000 | 384 |

Number of pigs present in the population

Minimum sample size (1)

> 20 000 000

2 400

10 to 20 000 000

1 067

2 to 10 000 000

600

< 2 000 000

384

Member States shall take a 10 % extra number of samples, to be analyzed in case some samples would be excluded from the study for various reasons.

Samplings shall be stratified by month to ensure to cover the different seasons.

Sampling shall be stratified by slaughterhouses that participate and proportional to slaughterhouse capacity. Each Member State shall rank all slaughterhouses according to their fattening pigs throughput in the previous year. Thus, each Member State shall identify those plants that accounted for at least 80 % of all slaughtered fattening pigs.

The total number of pigs and carcases to be sampled in each of the slaughterhouses included in the study shall be estimated by multiplying the sample size (e.g. 2 400) by the proportion of fattening pigs processed in the previous year. For example, if one slaughterhouse accounted for 25 % of fattening pigs slaughtered in the selected slaughterhouses (those representing at least 80 % of all fattening pigs slaughtered in the Member State), then (2 400 × 0,25) 600 pigs shall be sampled. These shall be evenly divided so that 50 pigs were sampled in every month, for 12 months. A further example is shown in Table 2.

Naturally, if a slaughterhouse is no longer in production, if a new facility has been opened or there is predicted to be a significant change in plant throughput during the survey, then the estimated throughput shall be adjusted accordingly.

Table 2

Weighing of slaughterhouses for the purpose of allocating the number of fattening pigs to be sampled from each slaughterhouse; calculation of sampled animals per slaughterhouse

| Slaughterhouse ID | Number of fattening pigs processed previous year | Percent of total slaughter included in the study | Number of samples per slaughterhouse | Samples per month
  (/12) |
| --- | --- | --- | --- | --- |
| AXD | 88 000 | 17,6 | 0,176 × 2 400 = 422,4 | 422,4:12 = 36 |
| SVH | 25 000 | 5,0 | | |
| TPB | 75 000 | 15,0 | | |
| MLG | 100 000 | 20,0 | | |
| GHT | 212 000 | 42,4 | | |
| Total | 500 000  (2) | 100,0 | | |

Slaughterhouse ID

Number of fattening pigs processed previous year

Percent of total slaughter included in the study

Number of samples per slaughterhouse

Samples per month

(/12)

AXD

88 000

17,6

0,176 × 2 400 = 422,4

422,4:12 = 36

SVH

25 000

5,0

TPB

75 000

15,0

MLG

100 000

20,0

GHT

212 000

42,4

Total

500 000  (2)

100,0

For each slaughterhouse each month, a number between 1 and 31 shall be selected at random. If the randomly selected number is a slaughtering day, for that month, then that day is selected for sampling. If not, then a new number is selected randomly. This process is performed once a month and repeated so many times as there are samples to be collected at the slaughterhouse. For example, in the slaughterhouse AXD the process shall be repeated at least 36 times to select at least 36 working days randomly. Naturally, it might be more than one carcase to be sampled on the same day.

As the number of animals slaughtered on a specific day may vary enormously, the random selection of the individual animal shall take place at the slaughterhouse at the day randomly selected for sampling. The given day, the total number of animals is known, and the personnel of the slaughterhouse shall then randomly select a carcase or carcases using the randomisation sheet which has been provided to them and which has been generated using a maximum that exceeds the highest possible number of fattening pigs slaughtered on any given day in any slaughterhouse in the Member State.

A randomisation table may then look as shown in Table 3.

Table 3

Randomisation table

| Slaughterhouse | Day of the month | Identity of carcase (3) |
| --- | --- | --- |
| AXD | 19 | 5 |
| 4 | 2 |
| 12 | 124 |
| 12 | 2 |
| 8 | 59 |

Slaughterhouse

Day of the month

Identity of carcase (3)

AXD

19

5

4

2

12

124

12

2

8

59

The following animals shall be excluded from the baseline study:

| — | animals with a live weight of less than 50 kg or more than 170 kg, |
| --- | --- |

—

animals with a live weight of less than 50 kg or more than 170 kg,

| — | animals that have undergone emergency slaughter, |
| --- | --- |

—

animals that have undergone emergency slaughter,

| — | any carcase that is totally condemned. |
| --- | --- |

—

any carcase that is totally condemned.

2.   Samples

2.1.   Sampling in general

The following samples shall be collected:

| — | the aggregate of ileocaecal lymph nodes or at least five individual ileocaecal lymph nodes of all selected pigs. If possible, at least 25 grams of lymph nodes without fat or connective tissues shall be collected, |
| --- | --- |

—

the aggregate of ileocaecal lymph nodes or at least five individual ileocaecal lymph nodes of all selected pigs. If possible, at least 25 grams of lymph nodes without fat or connective tissues shall be collected,

| — | a sponge swabbed at four sites in accordance with paragraph 2(3), per carcase, from a total of at least 384 pigs, randomly selected from the selected pigs. The sponge sampling method shall be used in accordance with the most recent edition of standard ISO 17604. This sampling shall be carried out in Belgium, the Czech Republic, Denmark, France, Ireland, Cyprus, Latvia, Lithuania, Austria, Poland, Slovenia, Sweden and the United Kingdom, |
| --- | --- |

—

a sponge swabbed at four sites in accordance with paragraph 2(3), per carcase, from a total of at least 384 pigs, randomly selected from the selected pigs. The sponge sampling method shall be used in accordance with the most recent edition of standard ISO 17604. This sampling shall be carried out in Belgium, the Czech Republic, Denmark, France, Ireland, Cyprus, Latvia, Lithuania, Austria, Poland, Slovenia, Sweden and the United Kingdom,

| — | a muscle sample for serology on meat juice or blood (if equivalent to the method on meat juice) from all selected pigs. Sufficient neck or diaphragm muscle shall be taken to yield enough meat juice to allow a portion to be frozen and stored for later comparative studies. This sampling shall be carried out in Denmark, Germany, France, Ireland, Cyprus, Lithuania, the Netherlands, Slovenia, Sweden and the United Kingdom. |
| --- | --- |

—

a muscle sample for serology on meat juice or blood (if equivalent to the method on meat juice) from all selected pigs. Sufficient neck or diaphragm muscle shall be taken to yield enough meat juice to allow a portion to be frozen and stored for later comparative studies. This sampling shall be carried out in Denmark, Germany, France, Ireland, Cyprus, Lithuania, the Netherlands, Slovenia, Sweden and the United Kingdom.

Records shall be kept at the slaughterhouse on the muscle which is sampled, time and date of sampling of each sample and the time and date and name of the courier that takes delivery of the samples.

2.2.   Details on sampling of ileocaecal lymph nodes

The mesenterium between the caecum and the part of the ileum that is closest to the caecum shall be torn and the ileocaecal lymph nodes are presented at the surface of the torn-open area. Without a knife, but with gloved fingers, the lymph nodes shall be bluntly ‘harvested’ from such opened mesenterium if individual lymph nodes are collected. The lymph nodes or the aggregate shall be placed in a plastic bag which is marked with date, time, slaughterhouse identification and sample identification code.

2.3.   Details on carcase sampling by surface swabs-sampling

Sampling of the carcase shall be performed after evisceration and before chilling. A surface of about 100 cm2 per site shall be swabbed using one single abrasive sponge for all the following sites as indicated and numbered below in accordance with Annex A of standard ISO 17604:

| — | hind limb, medial (9), |
| --- | --- |

—

hind limb, medial (9),

| — | abdomen, lateral (belly, 3), |
| --- | --- |

—

abdomen, lateral (belly, 3),

| — | mid-dorsal region (mid-back, 4), |
| --- | --- |

—

mid-dorsal region (mid-back, 4),

| — | jowl (7). |
| --- | --- |

—

jowl (7).

Two sites shall be swabbed with one side of the sponge, which shall then be turned over for the remaining two sites, and a scrubbing action shall be used. Enough pressure shall be used to push the lower part of the carcase slightly (2 to 5 mm) away from the sampler. The sponge shall be wiped over each sampling site for a total of approximately 10 times in the vertical and 10 times in the horizontal direction. If templates are used, precautions shall be taken to avoid cross-contamination between carcases.

The sample shall be kept at max. 7 °C during storage and transportation. The plastic bag is marked with the date, time, slaughterhouse identification and sample identification code.

3.   Transport

Samples shall be sent within 36 hours by fast mail or courier and shall reach the laboratory no later than 72 hours after sampling. Samples arriving later than within 72 hours after sampling shall be discarded unless analysis is initiated within 96 hours after sampling and the cold chain was not interrupted.

4.   Analysis of samples

Analysis and serotyping shall take place at the National Reference Laboratory (NRL). In case that the NRL does not have the capacity to perform all analyses or if it is not the laboratory that performs detection routinely, the competent authorities may decide to designate a limited number of other laboratories involved in official control of Salmonella to perform the analyses. These laboratories should have proven experience of using the required detection method and have a quality assurance system complying with ISO standard 17025 and be submitted to the supervision of the NRL.

At the laboratory, samples shall be kept refrigerated until bacteriological examination, which shall be carried out within 24 hours after receipt and so that analysis is initiated no later than 96 hours after the sample was collected.

The muscle sample for serology shall be kept frozen until analysis, which shall be carried out immediately after thawing.

4.1.   Sample preparation for bacteriology

Lymph nodes shall be surface de-contaminated before analysis by dipping into absolute alcohol and drying by air.

All lymph nodes shall be pooled and closed in a plastic bag and banged with a hammer or so on the plastic bag smashing the lymph nodes.

The homogenised lymph nodes shall be weighed and placed in a sterile container with pre-warmed buffered peptone water (BPW) in dilution 1:10. Containers shall be incubated for a total of (18 ± 2) hours at (37 ± 1) °C.

Regarding swabs sample, at the laboratory, 100 ml of BPW shall be added for pre-enrichment. The sample shall be incubated at 37 °C overnight and examined for Salmonella using the modified semi-solid Rappaport-Vassiladis medium (MRSV) method (draft Annex D of the ISO 6579:2002(E).

4.2.   Detection method for bacteriology

The method recommended by the Community Reference Laboratory (CRL) for Salmonella in Bilthoven, the Netherlands, shall be used. This method is described in the current version of draft Annex D of ISO 6579:2002: ‘Detection of Salmonella spp. in animal faeces and in samples of the primary production stage.’ In this method, MSRV shall be used as the single selective enrichment medium.

4.3.   Serotyping

All strains isolated and confirmed as Salmonella spp. shall be serotyped according to the Kaufmann-White scheme.

For quality assurance, 16 typable strains and 16 non-typable isolates shall be sent to the CRL. If less strains have been isolated, all shall be sent.

4.4.   Phage typing

In case isolates of Salmonella serovar typhimurium and Salmonella serovar enteritidis are phage typed (optional), the methods described by WHO reference centre for phage typing of Salmonella of the Health Protection Agency (HPA), Colindale, United Kingdom, shall be used.

4.5.   Testing of anti-microbial susceptibility

In case of testing for anti-microbial susceptibility (optional), a validated and controlled method for testing shall be used, such as those recommended by the National Committee for Clinical Laboratory Standards (NCCLS, since 1 January 2005: ‘Clinical and Laboratory Standards Institute’ — CLSI).

Both agar diffusion and broth dilution methods are acceptable. Results shall be reported both as quantitative data (MIC for dilution methods and inhibition zone diameter for diffusion methods) and as qualitative data (proportion resistant isolates). Qualitative data shall be based on interpretation according to epidemiological cut-off values presented by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) at: http://www.eucast.org

The isolates shall be tested for the susceptibility to the antimicrobial substances listed below:

| — | Ampicillin or Amoxicillin, |
| --- | --- |

—

Ampicillin or Amoxicillin,

| — | Tetracycline, |
| --- | --- |

—

Tetracycline,

| — | Chloramphenicol, |
| --- | --- |

—

Chloramphenicol,

| — | Florfenicol, |
| --- | --- |

—

Florfenicol,

| — | Nalidixic acid, |
| --- | --- |

—

Nalidixic acid,

| — | Ciprofloxacin (preferably) or Enrofloxacin, |
| --- | --- |

—

Ciprofloxacin (preferably) or Enrofloxacin,

| — | Sulphonamide (preferably Sulfametoxazole), |
| --- | --- |

—

Sulphonamide (preferably Sulfametoxazole),

| — | Sulphonamide/Trimethoprim or Trimethoprim, |
| --- | --- |

—

Sulphonamide/Trimethoprim or Trimethoprim,

| — | Gentamicin, |
| --- | --- |

—

Gentamicin,

| — | Streptomycin, |
| --- | --- |

—

Streptomycin,

| — | Kanamycin (preferably) or Neomycin, |
| --- | --- |

—

Kanamycin (preferably) or Neomycin,

| — | third generation Cephalosporin, (preferably Cefotaxime), |
| --- | --- |

—

third generation Cephalosporin, (preferably Cefotaxime),

| — | Colistin (optional). |
| --- | --- |

—

Colistin (optional).

Before initiation of the study Member States are encouraged to organise training for the involved parties.

5.   Records and sample storage

Records of bacteriology shall be kept on all samples processed in a format like or comparable to the example given in Table 4.

All strains isolated shall be stored at the NRLs of the different Member States as long as it ensures integrity of the strains for a minimum of five years.

All samples of meat juice for serology shall be stored frozen for two years.

Table 4

Example of records to be taken on all processed samples

| Sample | Receipt | Analysis |
| --- | --- | --- |
| Sample ID + type (4) | Slaughterhouse ID | Name | Date | Time | Name | Date | Time | Positive or Negative | Serovar | Phagetype | Antibiogram | Storage ID |
| 1 S | EU012 | PW | 3-10-06 | 12:00 | AB | 3-10 | 14:00 | Neg | | | | |
| 2 L | EU023 | PW | 4-10 | 12:30 | AB | 4-10 | 14:00 | Pos | Typh | DT104 | ASTSu | (IDnr) |
| 3 L | EU083 | PW | 8-10 | 16:30 | AB | 9-10 | 9:00 | Pos | Agona | n.a. (5) | ASTE | (IDnr) |

Sample

Receipt

Analysis

Sample ID + type (4)

Slaughterhouse ID

Name

Date

Time

Name

Date

Time

Positive or Negative

Serovar

Phagetype

Antibiogram

Storage ID

1 S

EU012

PW

3-10-06

12:00

AB

3-10

14:00

Neg

2 L

EU023

PW

4-10

12:30

AB

4-10

14:00

Pos

Typh

DT104

ASTSu

(IDnr)

3 L

EU083

PW

8-10

16:30

AB

9-10

9:00

Pos

Agona

n.a. (5)

ASTE

(IDnr)

6.   Reporting from Member States

The competent authority responsible for the preparation of the yearly national report on the monitoring of Salmonella in animals pursuant to Article 9 of Directive 2003/99/EC shall collect and evaluate the results and report to the Commission.

Reports shall be made including at least the following information:

6.1.   Overall description on the implementation of the programme

| — | description of the population under study stratified according to slaughterhouses capacity, |
| --- | --- |

—

description of the population under study stratified according to slaughterhouses capacity,

| — | description of randomisation procedure, including notification system, |
| --- | --- |

—

description of randomisation procedure, including notification system,

| — | sample size calculated, |
| --- | --- |

—

sample size calculated,

| — | details of authorities and laboratories involved in sampling/testing/typing, |
| --- | --- |

—

details of authorities and laboratories involved in sampling/testing/typing,

| — | overall results of the study (samples analysed by bacteriology and serology, number of positive, serovar, phage type and antibiotic resistance testing). |
| --- | --- |

—

overall results of the study (samples analysed by bacteriology and serology, number of positive, serovar, phage type and antibiotic resistance testing).

6.2.   Complete data on each animal sampled and corresponding tests results:

The Member States shall submit the results of the investigation in the form of raw data using a data dictionary and data collection forms provided by the Commission. This dictionary and forms shall be established by the Commission:

| — | reference of the slaughterhouse, |
| --- | --- |

—

reference of the slaughterhouse,

| — | capacity of the slaughterhouse, |
| --- | --- |

—

capacity of the slaughterhouse,

| — | date and time of sampling, |
| --- | --- |

—

date and time of sampling,

| — | reference of the samples (e.g. number), |
| --- | --- |

—

reference of the samples (e.g. number),

| — | type of samples taken: lymph nodes, carcase swab, |
| --- | --- |

—

type of samples taken: lymph nodes, carcase swab,

| — | date of shipment to the laboratory. |
| --- | --- |

—

date of shipment to the laboratory.

The following information shall be collected in Member States for each sample sent to the laboratory:

| — | ID of the laboratory (in case several laboratories are involved), |
| --- | --- |

—

ID of the laboratory (in case several laboratories are involved),

| — | means of transport of samples, |
| --- | --- |

—

means of transport of samples,

| — | date of reception by the laboratory, |
| --- | --- |

—

date of reception by the laboratory,

| — | when testing lymph nodes, weight of the specimen, |
| --- | --- |

—

when testing lymph nodes, weight of the specimen,

| — | result for the individual sample tested: ‘negative’ or in case positive for Salmonella spp., also the results of serotyping ‘
  Salmonella serovar’ or ‘untypable’, |
| --- | --- |

—

result for the individual sample tested: ‘negative’ or in case positive for Salmonella spp., also the results of serotyping ‘
  Salmonella serovar’ or ‘untypable’,

| — | results for strains subject to antimicrobial susceptibility testing and/or phagetyping results. |
| --- | --- |

—

results for strains subject to antimicrobial susceptibility testing and/or phagetyping results.

---

(1)  Based on an infinite population (> 100 000 per year), an estimated prevalence of 50 %, a confidence level of 95 % and a accuracy of 2, 3, 4 and 5 % respectively.

(2)  This number should represent at least 80 % of slaughtered fattening pigs in a Member State.

(3)  i.e. the fifth carcase to be processed on the 19th day of that month should be sampled for the survey.

(4)  Type of sample: L = lymph nodes, S = swab, MJ = meat juice.

(5)  n.a. = not applicable (phage typing is only done after Salmonella typhimurium and Salmonella enteritidis isolation).

---

ANNEX II

Maximum Community financial contribution to the Member States

| (in EUR) |
| --- |
| Member State | Amount |
| Belgium — BE | 25 584 |
| Czech Republic — CZ | 25 584 |
| Denmark — DK | 48 396 |
| Germany — DE | 86 400 |
| Estonia — EE | 9 984 |
| Greece — EL | 9 984 |
| Spain — ES | 62 400 |
| France — FR | 48 396 |
| Ireland — IE | 23 808 |
| Italy — IT | 15 600 |
| Cyprus — CY | 23 808 |
| Latvia — LV | 19 968 |
| Lithuania — LT | 23 808 |
| Luxembourg — LU | 9 984 |
| Hungary — HU | 15 600 |
| Malta — MT | 9 984 |
| Netherlands — NL | 38 412 |
| Austria — AT | 25 584 |
| Poland — PL | 37 726 |
| Portugal — PT | 15 600 |
| Slovenia — SI | 23 808 |
| Slovakia — SK | 9 984 |
| Finland — FI | 9 984 |
| Sweden — SE | 23 808 |
| United Kingdom — UK | 31 584 |
| Total | 675 778 |

(in EUR)

Member State

Amount

Belgium — BE

25 584

Czech Republic — CZ

25 584

Denmark — DK

48 396

Germany — DE

86 400

Estonia — EE

9 984

Greece — EL

9 984

Spain — ES

62 400

France — FR

48 396

Ireland — IE

23 808

Italy — IT

15 600

Cyprus — CY

23 808

Latvia — LV

19 968

Lithuania — LT

23 808

Luxembourg — LU

9 984

Hungary — HU

15 600

Malta — MT

9 984

Netherlands — NL

38 412

Austria — AT

25 584

Poland — PL

37 726

Portugal — PT

15 600

Slovenia — SI

23 808

Slovakia — SK

9 984

Finland — FI

9 984

Sweden — SE

23 808

United Kingdom — UK

31 584

Total

675 778

---

ANNEX III

Image 1

Certified financial report on the implementation of a baseline survey on the prevalence of Salmonella spp. in herds of fattening pigs

Reporting period: to

Statement on costs incurred on the survey and eligible for Community financial contribution:

Reference number of Commission Decision providing Community financial contribution:

| Costs incurred related to functions at/by | Number of tests | Total costs of testing incurred during reporting period (national currency) |
| --- | --- | --- |
| Bacteriology for Salmonella spp. | | |
| Serotyping Salmonella isolates | | |
| Serology meat juice | | |

Costs incurred related to functions at/by

Number of tests

Total costs of testing incurred during reporting period (national currency)

Bacteriology for Salmonella spp.

Serotyping Salmonella isolates

Serology meat juice

Declaration by the beneficiary

We certify that

the above costs are genuine and have been incurred in carrying out the tasks laid down in this Decision and were essential for the proper performance of those tasks;

all supporting documents supporting for the costs are available for audit purposes.

Date:

Person financially responsible:

Signature:

---